Clinical Trial Update: Evaluation of Exposure Reduction Using Region-of-Interest Fluoroscopy (X-ray Fovea Imaging) in Cardiac Interventions [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating exposure reduction using region-of-interest fluoroscopy (X-ray fovea imaging) in cardiac interventions; status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Cardiovascular Diseases | Phase 1 | Status: UNKNOWN